| HOME >> BIOLOGY >> TECHNOLOGY |
adjustments 2,175,433 563,945
Comprehensive income $14,994,966 $9,151,031
Earnings Per Share:
Basic $ 0.35 $ 0.25
Diluted $ 0.34 $ 0.25
Weighted Average Shares
Outstanding:
Basic 37,009,655 34,723,056
Diluted 37,259,909 34,723,056
CHINA PHARMA HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the years ended December 31,
2007 2006
Cash Flows from Operating Activities:
Net income $12,819,533 $8,587,086
Depreciation and amortization 422,443 397,001
Gain on sale of intangibles (580,922) --
Changes in assets and liabilities:
Trade accounts receivable (5,413,718) (6,077,526)
Other receivables (111,660) 42,642
Advances to suppliers (1,028,199) (61,345)
Inventory (3,325,681) (4,214,702)
Deferred tax assets (162,872) 115,564
Deferred offering costs 60,952 --
Trade accounts payable (204,372) (219,427)
Accrued expenses 73,451 86,265
Accrued taxes payable 126,812 (407,744)
Other payables 20,558 (71,759)
Advances from customers
'/>"/>
| SOURCE China Pharma Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved |